In patients with heart failure the burden of central sleep apnea increases in the late sleep hours.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 22 02 2018
pubmed: 17 10 2018
medline: 19 12 2019
entrez: 17 10 2018
Statut: ppublish

Résumé

Periodic breathing with central sleep apnea (CSA) is common in patients with left ventricular systolic dysfunction. Based on the pathophysiological mechanisms underlying CSA, we hypothesized that the frequency of CSA episodes would increase in the late hours of non-rapid eye movement (NREM) of sleep. Forty-one patients with left ventricular ejection fraction <40% underwent full-night-attended polysomnography scored by a central core lab. Because central apneas occur primarily in NREM sleep, total NREM sleep time for each patient was divided into 8 equal duration segments. Segment event counts were normalized to an events/hour index based on sleep segment duration. Central apnea index (CAI) varied among sleep segments (p = 0.001). As expected CAI was higher in segment 1 compared to segments 2 and 3, increasing during later segments. The minimum CAI occurred in segment 2 with mean ± SD of 21 ± 3 events/hour and maximum CAI was in segment 8 with 37 ± 4 events/hour. We also determined central apnea duration which varied among segments (p = 0.005), with longer durations later in the night (segment 1: 22 ± 1 seconds; segment 8: 26 ± 1 seconds, p < 0.001). Data were also analyzed including rapid eye movement (REM) sleep, with similar results. Further, comparison of CAI between the first and second half of the night showed a significant increase in the index. Circulation time did not change across the segments (p = 0.073). In patients with left ventricular dysfunction and CSA, central apnea burden (number and duration) increases during later hours of sleep. These findings have pathophysiological and therapeutic implications. NCT01124370.

Identifiants

pubmed: 30325462
pii: 5133062
doi: 10.1093/sleep/zsy195
pmc: PMC6609878
doi:

Banques de données

ClinicalTrials.gov
['NCT01124370']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NHLBI NIH HHS
ID : K24 HL132105
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL085188
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL134632
Pays : United States

Références

Compr Physiol. 2013 Jan;3(1):141-63
pubmed: 23720283
J Clin Sleep Med. 2007 Mar 15;3(2):133-45
pubmed: 17557423
J Appl Physiol (1985). 2010 Feb;108(2):369-77
pubmed: 19940101
Respir Physiol Neurobiol. 2013 Sep 15;188(3):289-300
pubmed: 23587570
Chest. 2016 Apr;149(4):900-4
pubmed: 26836904
J Clin Sleep Med. 2018 Jun 15;14(6):923-925
pubmed: 29852919
Curr Opin Pulm Med. 2009 Nov;15(6):565-70
pubmed: 19713849
J Appl Physiol (1985). 2006 Jul;101(1):76-83
pubmed: 16627673
Eur Heart J. 2015 Jun 14;36(23):1463-9
pubmed: 25636743
J Am Coll Cardiol. 2007 May 22;49(20):2028-34
pubmed: 17512359
Circulation. 2001 Jan 16;103(2):238-43
pubmed: 11208683
J Clin Sleep Med. 2018 Jun 15;14(6):915-921
pubmed: 29852913
Am J Respir Crit Care Med. 1999 Oct;160(4):1101-6
pubmed: 10508793
Circulation. 2003 Feb 11;107(5):727-32
pubmed: 12578876
Int J Cardiol. 2006 Jan 4;106(1):21-8
pubmed: 16321661
J Am Coll Cardiol. 2015 Jan 6;65(1):72-84
pubmed: 25572513
Eur Heart J. 2016 Jun 1;37(21):1695-703
pubmed: 26612581
Chest. 1994 Dec;106(6):1695-701
pubmed: 7988186
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):988-93
pubmed: 8887596
Can J Cardiol. 2015 Jul;31(7):898-908
pubmed: 26112300
Sleep. 2018 May 1;41(5):
pubmed: 29741725
Circulation. 1998 Jun 2;97(21):2154-9
pubmed: 9626176
N Engl J Med. 2015 Sep 17;373(12):1095-105
pubmed: 26323938
Am Rev Respir Dis. 1990 Apr;141(4 Pt 1):871-9
pubmed: 2327649
Ann Intern Med. 1995 Apr 1;122(7):487-92
pubmed: 7872582
Eur J Heart Fail. 2015 Dec;17(12):1302-9
pubmed: 26467056
JACC Heart Fail. 2015 May;3(5):360-369
pubmed: 25770408

Auteurs

Shahrokh Javaheri (S)

Bethesda Montgomery Sleep Centre, Bethesda North Hospital, Cincinnati, OH.

Scott W McKane (SW)

Respicardia, Inc., Minnetonka, MN.

Nathan Cameron (N)

St. Paul Rheumatology, P.A., St. Paul, MN.

Robin E Germany (RE)

Respicardia, Inc., Minnetonka, MN.
Division of Cardiovascular Diseases, University of Oklahoma College of Medicine, Oklahoma City, OK.

Atul Malhotra (A)

Division of Pulmonary, Critical Care and Sleep Medicine, University of California at San Diego, San Diego, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH